[1] HONARDOOST M, SAROOKHANI MR, AREFIAN E, et al.Insulin resistance associated genes and mirnas. Appl Biochem Biotechnol. 2014;174(1):63-80.
[2] BRAVO-EGANA V, ROSERO S, MOLANO RD, et al. Quantitative differential expression analysis reveals mir-7 as major islet microrna. Biochem Biophys Res Commun.2008;366(4):922-926.
[3] KADAMKODE V, BANERJEE G. Micro rna: An epigenetic regulator of type 2 diabetes. Microrna. 2014;3(2):86-97.
[4] MAO Y, MOHAN R, ZHANG S, et al. Micrornas as pharmacological targets in diabetes. Pharmacol Res. 2013;75:37-47.
[5] 胡蕴,毛晓明.Mirna在2型糖尿病中的研究进展[J].医学研究生学报, 2011,24(9):1003-1006.
[6] CHEN L, CAO ZL, HAN F, et al. Chronic intermittent hypoxia from pedo-stage decreases glucose transporter 4 expression in adipose tissue and causes insulin resistance. Chin Med J (Engl). 2010;123(4):463-470.
[7] FU C, JIANG L, ZHU F, et al. Chronic intermittent hypoxia leads to insulin resistance and impaired glucose tolerance through dysregulation of adipokines in non-obese rats. Sleep Breath. 2015;19(4):1467-1473.
[8] KLÖTING N, BERTHOLD S, KOVACS P, et al. Microrna expression in human omental and subcutaneous adipose tissue. Plos One. 2009;4(3):e4699.
[9] CHAKRABORTY C1, GEORGE PRIYA DOSS C, BANDYOPADHYAY S. Mirnas in insulin resistance and diabetes-associated pancreatic cancer: The 'minute and miracle' molecule moving as a monitor in the 'genomic galaxy'. Curr Drug Targets. 2013;14(10):1110-1107.
[10] FENG J, XING W, XIE L. Regulatory roles of micrornas in diabetes. Int J Mol Sci. 2016;17(10). pii: E1729.
[11] WU L, DAI X, ZHAN J, et al.Profiling peripheral micrornas in obesity and type 2 diabetes mellitus. Apmis.2015;123(7): 580-585.
[12] HINAULT C, DUMORTIER O, VAN OBBERGHEN E. microrna and diabetes: Tiny things causing huge effects. Med Sci (Paris). 2013;29(8-9):785-790.
[13] VICKERS KASEY C, SHOUCRI BASSEM M, LEVIN MICHAEL G,et al Microrna‐27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia. Hepatology.2013; 57(2): 533-542.
[14] NING H, TAO H, WENG Z,et al.Plasma fatty acid-binding protein 4 (fabp4) as a novel biomarker to predict gestational diabetes mellitus. Acta Diabetologica.2016; 53(6):1-8.
[15] VENIGALLA RK, TURNER M.Rna-binding proteins as a point of convergence of the pi3k and p38 mapk pathways. Front Immunol. 2012;3:398.
[16] GUAY C,REGAZZI R.Circulating micrornas as novel biomarkers for diabetes mellitus. Nat Rev Endocrinol. 2013;9(9):513-521.
[17] PRABU P, ROME S, SATHISHKUMAR C, et al. Circulating mirnas of 'asian indian phenotype' identified in subjects with impaired glucose tolerance and patients with type 2 diabetes. Plos One. 2015;10(5): e0128372.
[18] 汪娅. Hmga2及let--7d mirna对糖尿病肾脏病肾小管上皮细胞转分化及肾脏纤维化的调控[D]. 广州:南方医科大学,2017.
[19] 张冬雪,陈璐璐,廖云飞.微小rna在2型糖尿病相关机制中的研究进展[J]. 中华内分泌代谢杂志, 2012,28(11):944-947.
[20] 尤卫绝.Mir-24在糖尿病胰岛β细胞损伤中的作用和机制研究[D]. 南京:南京医科大学,2016.
[21] 郑宗基.Mir-26a和mir-30c协同调控tgfβ1诱导肾小管上皮细胞转分化在糖尿病肾脏病中的作用机制研究[D]. 广州:南方医科大学, 2016.
[22] XU G, SHI C, JI C, et al. Expression of microrna-26b, an obesity-related microrna, is regulated by free fatty acids, glucose, dexamethasone and growth hormone in human adipocytes. Mol Med Rep. 2014;10(1):223-228.
[23] KAJIMOTO K, NARABA H, IWAI N. Microrna and 3t3-l1 pre-adipocyte differentiation. Rna-a Publication of the Rna Society. 2006;12(9):1626-1632.
[24] XU G, JI C, SONG G,et al. Mir-26b modulates insulin sensitivity in adipocytes by interrupting the pten/pi3k/akt pathway. Int J Obes (Lond). 2015;39(10):1523-1530.
[25] 孟娅妮,于海伦. 7-二氟甲氧基-5,4'-二甲氧基金雀异黄素上调mir-26b对妊娠期糖尿病脂肪细胞葡萄糖摄取的影响[J].中国现代应用药学,2017,34(8):1104-1108.
[26] KARBIENER M, FISCHER C, NOWITSCH S, et al.Microrna mir-27b impairs human adipocyte differentiation and targets ppargamma. Biochem Biophys Res Commun. 2009;390(2):247-251.
[27] LEE EK, LEE MJ, ABDELMOHSEN K, et al.Mir-130 suppresses adipogenesis by inhibiting peroxisome proliferator-activated receptor gamma expression. Mol Cell Biol. 2011;31(4):626-638.
[28] KENNELL JA, GERIN I, MACDOUGALD OA, et al. The microrna mir-8 is a conserved negative regulator of wnt signaling. Proc Natl Acad Sci U S A. 2008;105(40):15417-15422.
[29] BHATIA P, RAINA S, CHUGH J, et al. Mirnas: Early prognostic biomarkers for type 2 diabetes mellitus?. Biomark Med. 2015; 9(10):1025-1040.
[30] CHEN H, LAN HY, ROUKOS DH, et al. Application of micrornas in diabetes mellitus. J Endocrinol. 2014;222(1):R1-R10.
[31] GONG W, XIAO D, MING G, et al. Type 2 diabetes mellitus- related genetic polymorphisms in micrornas and microrna target sites. J Diabetes. 2014;6(4):279-289.
[32] MIRRA P, RACITI GA, NIGRO C, et al. Circulating mirnas as intercellular messengers, potential biomarkers and therapeutic targets for type 2 diabetes. Epigenomics. 2015; 7(4):653-667.
[33] PARK SY, JEONG HJ, YANG WM, et al. Implications of micrornas in the pathogenesis of diabetes. Arch Pharm Res. 2013;36(2): 154-166.
[34] LESLIE WS, FORD I, SATTAR N, et al. The diabetes remission clinical trial (direct): Protocol for a cluster randomised trial. Bmc Family Practice. 2016;17(1):20.
[35] 陆康,李晔. Mirna与糖脂代谢[J].生命的化学, 2016, 36(3): 347-353.
[36] MOTOHASHI N, ALEXANDER MS, SHIMIZU-MOTOHASHI Y,et al. Regulation of irs1/akt insulin signaling by microrna-128a during myogenesis. J Cell Sci. 2013;126(Pt 12):2678-2691.
[37] CORREA-MEDINA M, BRAVO-EGANA V, ROSERO S, et al. Microrna mir-7 is preferentially expressed in endocrine cells of the developing and adult human pancreas. Gene Expr Patterns. 2009; 9(4):193-199.
[38] KREDO-RUSSO S, NESS A, MANDELBAUM AD, et al. Regulation of pancreatic microrna-7 expression. 2014; 2012(10): 695214.
[39] KREDO-RUSSO S, MANDELBAUM AD, NESS A, et al. Pancreas-enriched mirna refines endocrine cell differentiation. Development. 2012;139(16):3021-3031.
[40] WEI R, YANG J, LIU GQ, et al. Dynamic expression of micrornas during the differentiation of human embryonic stem cells into insulin-producing cells. Gene.2013;518(2): 246-255.
[41] KORNFELD JW, BAITZEL C, KÖNNER AC, et al. Obesity-induced overexpression of mir-802 impairs glucose metabolism through silencing of hnf1b. Nature.2013; 494(7435): 111-115.
[42] JORDAN SD, KRÜGER M, WILLMES DM,ET AL. OBESITY-INDUCED OVEREXPRESSION OF MIRNA-143 INHIBITs insulin-stimulated akt activation and impairs glucose metabolism. Nature Cell Biology.2011; 13(4): 434-446.
[43] TRAJKOVSKI M, HAUSSER J, SOUTSCHEK J, et al. Micrornas 103 and 107 regulate insulin sensitivity. Nature.2011;474(7353): 649.
[44] VIVACQUA A, DE MARCO P, BELFIORE A,et al. Recent advances on the role of micrornas in both insulin resistance and cancer. Curr Pharm Des. 2017;23(25):3658-3666.
[45] OLIVIERI F, RIPPO MR, PRATTICHIZZO F, et al.Toll like receptor signaling in “inflammaging”: Microrna as new players. Immun Ageing. 2013;10(1):11.
[46] WANG R, HONG J, CAO Y, et al. Elevated circulating microrna-122 is associated with obesity and insulin resistance in young adults. Eur J Endocrinol. 2015;172(3):291-300.
[47] ORTEGA FJ, MERCADER JM, CATALÁN V,et al. Targeting the circulating microrna signature of obesity. Clin Chem. 2013; 59(5): 781-792.
[48] SETYOWATI KAROLINA D, SEPRAMANIAM S, TAN HZ,et al. Mir-25 and mir-92a regulate insulin i biosynthesis in rats. Rna Biology. 2013;10(8):1365-1378.
[49] ORTEGA FJ, MERCADER JM, MORENO-NAVARRETE JM, et al. Profiling of circulating micrornas reveals common micrornas linked to type 2 diabetes that change with insulin sensitization. Diabetes Care. 2014; 37(5): 1375-1383.
[50] LI X. Mir-375, a microrna related to diabetes. Gene. 2014; 533(1): 1-4.
[51] CHAKRABORTY C, DOSS CG, BANDYOPADHYAY S, et al. Influence of mirna in insulin signaling pathway and insulin resistance: Micro-molecules with a major role in type-2 diabetes. Wiley Interdiscip Rev RNA. 2014;5(5):697-712.
[52] SUN LL, JIANG BG, LI WT, et al. Microrna-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression. Diabetes Res Clin Pract.2011; 91(1): 94-100.
[53] MICHAEL MZ, O' CONNOR SM, van Holst Pellekaan NG, et al. Reduced accumulation of specific micrornas in colorectal neoplasia. Mol Cancer Res. 2003;1(12):882-891.
[54] JOGLEKAR MV, PAREKH VS, MEHTA S,et al.Microrna profiling of developing and regenerating pancreas reveal post-transcriptional regulation of neurogenin3. Dev Biol. 2007; 311(2):603-612.
[55] ZAMPETAKI A, KIECHL S, DROZDOV I,et al.Plasma microrna profiling reveals loss of endothelial mir-126 and other micrornas in type 2 diabetes. Circ Res. 2010;107(6):810-817.
[56] BORK-JENSEN J, SCHEELE C, CHRISTOPHERSEN DV, et al. Glucose tolerance is associated with differential expression of micrornas in skeletal muscle: Results from studies of twins with and without type 2 diabetes. Diabetologia.2015; 58(2):363-373.
[57] YU Y, CHAI J. The function of mirnas and their potential as therapeutic targets in burn-induced insulin resistance (review). Int J Mol Med. 2015;35(2):305-310.
[58] MA H, ZHANG S, SHI D, et al. Microrna-26a promotes regulatory t cells and suppresses autoimmune diabetes in mice. Inflammation. 2015;39(1):1-9.
[59] FU X, DONG B, TIAN Y, et al. Microrna-26a regulates insulin sensitivity and metabolism of glucose and lipids. J Clin Invest. 2015;125(6):2497-2509.
[60] FERLAND-MCCOLLOUGH D, OZANNE SE, SIDDLE K, et al. The involvement of micrornas in type?2 diabetes. Biochem Soc Trans. 2010;38(6):1565-1570.
[61] FATJON L, MATTHEW T, JOHANNA DK. The role of ncrna in diabetes.Springer. 2015.
[62] 任彦红,黄婷,时学秀,等. 循环mirna-126在2型糖尿病患者中的表达变化及其相关性研究[J].中国糖尿病杂志,2014, 22(7): 633-636.
[63] 王宁琦,胡扬,官余凌,等. 4周低氧运动结合饮食控制对肥胖青年体重、血脂及胰岛素抵抗的影响[J].中国运动医学杂志,2012, 31(4): 289-294.
[64] 黄徐根,冯连世,徐建方,等. 低氧训练过程中大鼠体重及能量代谢的变化[J].体育科学,2007,27(10):61-68.
[65] 张荷,周越,张一民,等. 低氧运动对肥胖大鼠胰岛素抵抗及血脂代谢的影响[J].北京体育大学学报,2016,39(9):44-49,56.
[66] MACKENZIE R,MAXWELL N,CASTLE P, et al. Intermittent exercise with and without hypoxia improves insulin sensitivity in individuals with type 2 diabetes. J Clin Endocrinol Metab.2012; 97(4): E546.
[67] 李明锐,何劲松,吴让兵,等. Mirna?33在运动调节c57/bl6小鼠肥胖中的作用及机制探讨 [J]. 热带医学杂志,2017,17(8):1035-1038.
[68] 邵芳,朱斌,顾志良. Microrna在脂类代谢中的功能研究进展[J].生命科学, 2013, 25(7): 676-684.
[69] 杨卫利,王君佩,崔庆华,等.非编码rna与肝脏糖脂代谢调控[J].生理科学进展, 2016,47(3):194-202.
[70] ZHANG Y, LIU G, GAO X. Attenuation of mir-34a protects cardiomyocytes against hypoxic stress through maintenance of glycolysis . Biosci Rep. 2017;37(6). pii: BSR20170925.
[71] 林延艳,赵林双.运动诱导 mir-222在糖尿病小鼠心肌损害中的保护作用及机制[J].中华内分泌代谢杂志, 2017, 33(1):56-61.
[72] 林延艳,赵林双,刘意,等.有氧运动对糖尿病小鼠心肌保护的作用机制及其与微小核糖核酸222的相关性研究[J].中国糖尿病杂志, 2017, 25(2):163-167.
[73] HEMMATI AA, ALBOGHOBEISH S, AHANGARPOUR A.Chronic exposure to high fat diet exacerbates arsenic-induced lung damages in male mice: Possible role for oxidative stress. Monaldi Arch Chest Dis. 2018;88(1):903.
[74] 林文弢,李颖,翁锡全.间歇性低氧和运动对高脂饮食诱导胰岛素抵抗大鼠血清内脂素的影响[J].中国运动医学杂志,2008,27(2):161-164.
[75] 潘哲浩,翁锡全,朱宪锋,等.间歇低氧暴露对高脂膳食大鼠胰岛素敏感性的影响[J].中国运动医学杂志, 2012, 31(3): 244-247.
[76] MACKENZIE R, ELLIOTT B, MAXWELL N,et al. The effect of hypoxia and work intensity on insulin resistance in type 2 diabetes. J Clin Endocrinol Metab.2012;97(1):155-162.
[77] MACKENZIE R, MAXWELL N, CASTLE P,et al. Acute hypoxia and exercise improve insulin sensitivity (s(i) (2*)) in individuals with type 2 diabetes. Diabetes Metab Res Rev. 2011;27(1): 94-101.
[78] 谭健,莫海兰,李洁,等.慢性间歇性缺氧对大鼠骨骼肌葡萄糖转运蛋白4表达的影响 [J]. 南方医科大学学报, 2014,34 (7): 1061-1064.
|